According to Coherent Market Insights, the Middle East and Turkey hemophilia treatment market to grow 4.2% CAGR

▴ hemophilia treatment
A CAGR of 4.2% during the forecast period (2019-2027), owing to increasing product launches by key players.

Middle East and Turkey hemophilia treatment market is expected to witness significant growth over the forecast period, owing to increasing demand for hemophilia treatment option such as recombinant coagulation factor and plasma-derived coagulation factor concentrates in emerging economies such as Saudi Arabia and Turkey, which is expected to drive the segment growth during the forecast period. For instance, according to the reports published by the World Federation of Hemophilia in 2016, demand for plasma-derived coagulation factors is high compared to recombinant coagulation concentrate. Moreover, plasma-derived coagulation concentrate are easily available in emerging economies such as Turkey and Saudi Arabia.

Moreover, increasing research and development for the development of novel therapies and rising incidence of hemophilia B is expected to drive the market growth. For instance, in August 2019, Mitsubishi Tanabe Pharma and Jichi Medical University entered into a collaboration to launch research study program for the development of gene therapy products, which can be used in the treatment of Hemophilia B. Moreover, according to the World Federation of Hemophilia 2018 statistics, around 1,084 cases of hemophilia B were reported in 2017, in Egypt.

Middle East, Asia Pacific, and Africa are expected to be the potential markets for hemophilia, owing to increasing healthcare awareness along with supportive government initiatives towards patient care and prevention of bleeding disorders. This is expected to create a favorable environment for market players. For instance, in July 2019, UAE Ministry of Health & Prevention (MoHAP) signed a Memorandum of Understanding (MoU) with Swedish Orphan Biovitrum AB Middle East and Bayti Home Healthcare. The initiative is for patients with Hemophilia A and Hemophilia B, who have difficulty in visiting medical centers and, in order to support and improve adherence to the treatment protocols prescribed by the doctors.

Among countries, Israel hemophilia treatment market is expected to witness significant growth over the forecast period, owing to presence of research facilities in Israel, which aids in conducting clinical studies for hemophilia therapy. For instance, in April 2019, Sheba Medical Center, Tel HaShomer, an Israel-based hospital, is the first hospital in Middle East region that conducted phase III trial on humans using the innovative gene therapy developed by the U.S.-based pharmaceutical company.

Tags : #cagr #middleeast #turkey #haemophilia #medicircle

About the Author


Snehangshu Dasgupta,

Managing Editor
[email protected]

Related Stories

Loading Please wait...
-Advertisements-





Trending Now

Immunity was a luxury in India pre-covid, and today immunity is an essential says Arjun Vaidya, CEO, Dr. Vaidya’s: New Age AyurvedaJanuary 19, 2021
Dr. Chytra Anand, CEO, Kosmoderma Clinics explains How Education of the masses and increase GDP spending can help tackle the challenges of healthcareJanuary 19, 2021
India Covid Vaccine Rollout : A detailed state wise update Jan 19,2021January 19, 2021
Lakshadweep reports first Covid-19 case January 19, 2021
Country's COVID-19 recovery rate reaches 96.66 per cent; more than 3, 81000 people vaccinated so farJanuary 19, 2021
Biden stays the travel ban for passengers from UK, Brazil and EU countriesJanuary 19, 2021
US faces 400000 lakh deaths due to CoronavirusJanuary 19, 2021
Sirnaomics announces first patient dosed In phase 2a study of STP705January 18, 2021
Andhra Pradesh: 332 locations identified for rollout of COVID-19 vaccinationJanuary 18, 2021
COVID-19 Vaccination begins in Kargil at District HospitalJanuary 18, 2021
Jharkhand: Covid vaccination drive underway at all 49 centresJanuary 18, 2021
Higher coffee intake may be linked to lower prostate cancer riskJanuary 18, 2021
Vaccination drive against Covid-19 being carried out four days a week in West BengalJanuary 18, 2021
Short term low carbohydrate diet linked to remission of type 2 diabetesJanuary 18, 2021
Enhertu approved in the US for the treatment of patients with previously treated HER2-positive advanced gastric cancerJanuary 18, 2021
How important is nutrition for health?January 18, 2021
GSK presents positive efficacy data of dostarlimab in mismatch repair-deficient solid cancers at ASCO Gastrointestinal Cancers SymposiumJanuary 18, 2021
Avian Influenza confirmed in crow samples from Haridwar, Lansdowne forest range of UttarakhandJanuary 18, 2021
National COVID-19 recovery rate improves to 96.59 per centJanuary 18, 2021
Over 5, 48, 000 COVID samples tested in country in last 24 hoursJanuary 18, 2021